Showing results (11-20 of 1,311) with videos related to
Sort By:
Pageof 132
Brain Research|November 21, 2007
Epigenetic silencing of telomerase and a non-alkylating agent as a novel therapeutic approach for gliomaRahima Patel, Leroy Shervington, Robert Lea, et al.Cancers|November 12, 2013
A novel therapeutic strategy for the treatment of glioma, combining chemical and molecular targeting of hsp90aAdi Mehta, Leroy Shervington, Chinmay Munje, et al.Molecular Biology Reports|June 27, 2008
The sensitization of glioma cells to cisplatin and tamoxifen by the use of catechinAmal Shervington, Vidya Pawar, Sharad Menon, et al.FEBS Open Bio|August 2, 2013
Can RNAi-mediated hsp90α knockdown in combination with 17-AAG be a therapy for glioma?Adi Mehta, Amal Shervington, John Howl, et al.Biomarker Insights|September 29, 2018
Identifying Reliable Diagnostic/Predictive Biomarkers for Rheumatoid ArthritisLeroy Shervington, Ashish Darekar, Murassa Shaikh, et al.Cancer Investigation|March 10, 2010
Can hsp90alpha-targeted siRNA combined with TMZ be a future therapy for glioma?Nichola Cruickshanks, Leroy Shervington, Rahima Patel, et al.Cancer Investigation|September 18, 2008
Can the lack of HSP90alpha protein in brain normal tissue and cell lines, rationalise it as a possible therapeutic target for gliomas?Amal Shervington, Nichola Cruickshanks, Robert Lea, et al.European Journal of Medicinal Chemistry|January 6, 2009
To determine the cytotoxicity of chlorambucil and one of its nitro-derivatives, conjugated to prasterone and pregnenolone, towards eight human cancer cell-linesLeroy A Shervington, Nigel Smith, Emma Norman, et al.Prostaglandins & Other Lipid Mediators|August 9, 2024
Effect of PGE2 on TT cells viability and divisionChien-Chen LuProstaglandins & Other Lipid Mediators|May 28, 2026
Impact of COX-2 Inhibition by DuP-697 on Cyclin B1/Cdc2 Dynamics in Human Medullary Thyroid Carcinoma CellsChien-Chen LuPageof 132